Mar
6
Event Details
11:00 AM - 12:00 PM
Event Description
| Mark Schindel's 20+ years of experience spans medical device (Biomet, Zimmer, Tornier), pharma/biotech (Roche), and life-science (Vanderbilt Tech Transfer) including corporate, early-stage, and start-up environments. Mark has led multiple new product development and commercialization efforts across the globe, including surgical robotics/software, surgical implants, and biologic technologies among others.
From 2015-2021, Mark was co-founder, CEO, and board member for Owl Manor Medical, LLC, an animal health biologics / medical device company. Owl Manor established a successful US and international business (Europe, Middle East, Canada and Mexico) whose portfolio was acquired by Zoetis, Inc. in June 2021. Mark’s forte is evaluating, initiating, managing, and growing new business ventures/opportunities from inception through exit. |
Free
